Viewing StudyNCT00324363



Ignite Creation Date: 2024-05-05 @ 4:51 PM
Last Modification Date: 2024-10-26 @ 9:24 AM
Study NCT ID: NCT00324363
Status: COMPLETED
Last Update Posted: 2015-02-23
First Post: 2006-05-09

Brief Title: Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Metformin or Sulfonylureas and Metformin
Sponsor: AstraZeneca
Organization: AstraZeneca

Conditions & Keywords Data

Conditions:
Name
Type 2 Diabetes Mellitus
Keywords:
Name View
China View
exenatide View
diabetes View
Amylin View
Lilly View